ArticleJournal of clinical biochemistry and nutrition2022

Low immunogenicity of vedolizumab determined by a simple drug-tolerant assay in patients with ulcerative colitis.

Noriaki Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.